Anti-malaria genes give mosquitoes an edge

Transgenic mosquitoes resistant to malaria infection outcompete normal mosquitoes when feeding on infected blood

Written byMelissa Lee Phillips
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Researchers are one step closer to creating a viable malaria-resistant mosquito, according to a study in this week's Proceedings of the National Academy of Sciences. The authors found that, when feeding on malaria-infected blood, transgenic mosquitoes resistant to malaria infection experienced both higher fecundity and lower mortality than normal mosquitoes.If such a mosquito could be introduced into the wild, "you may end up with populations that are refractory to the transmission of the parasite," predicted Peter Atkinson of the University of California, Riverside, who was not involved in the study. Previous work has shown that mosquitoes infected with the malaria parasite are less fit than uninfected mosquitoes. This observation led to the hypothesis that transgenic malaria-resistant mosquitoes may outcompete wild-type mosquitoes, said study senior author Marcelo Jacobs-Lorena of Johns Hopkins Bloomberg School of Public Health. However, other studies have shown that transgenic mosquitoes may suffer a loss in fitness that balances out any gains from malaria resistance. "It was believed that just the presence of the transgene is a detriment," Jacobs-Lorena said. Led by Mauro T. Marrelli, also of Johns Hopkins, the researchers compared the fitness of wild-type Anopheles stephensi to that of mosquitoes expressing a peptide called SM1, which prevents the malaria parasite from invading the midgut. These transgenic mosquitoes cannot become infected with Plasmodium berghei, a malaria parasite that infects mice. The researchers placed equal numbers of wild-type and transgenic mosquitoes in a cage and fed them Plasmodium infected mouse blood. After nine generations, transgenic mosquitoes made up about 70% of the population. Additional experiments showed that transgenic mosquitoes had both higher fecundity and lower mortality than wild-type mosquitoes when fed blood containing reproducing parasites."It's very nice work," Atkinson said. "Some people have always said that if we make these things transgenic, they'll just be so unfit because they're genetically altered that they'll never be of any use, [so] it's actually very encouraging news."Previous studies have shown that a different type of malaria-resistant mosquito cannot outcompete wild-type mosquitoes. However, those transgenic mosquitoes fought the malaria parasite by upregulating the immune response, which "may impose costs on the mosquito that equal, or even outweigh, the benefits of not being infected," according to Hilary Hurd of Keele University in Staffordshire, UK, who was an author on these previous studies but was not involved in the current work. "The advantage of the SM1 peptide is that it is not part of the natural immune system and appears to inhibit infection by blocking parasite invasion rather than killing the parasite," Hurd told The Scientist in an Email.In order to have a viable system that could be introduced into the wild, scientists will still need to come up with a genetic drive mechanism to encourage the transgene to spread among mosquito populations, Jacobs-Lorena said. Even though transgenic mosquitoes outcompete wild-types in the lab, this is probably not sufficient "to promote introduction of the gene into the wild by itself," he said. But their results suggest that "we may need not as strong a drive force as originally predicted in order to accomplish this goal." Another important step is to replicate the findings using human malaria parasites in their natural mosquito vectors, according to Robert Sinden of Imperial College London, who was not involved in the study. "If the results are repeated under these conditions we will have reason to be optimistic for the future."Melissa Lee Phillips mail@the-scientist.comLinks within this articleL. Pray, "Scientists want to create a new kind of mosquito," The Scientist, November 25, 2002. http://www.the-scientist.com/article/display/13396/M. Marrelli et al., "Transgenic malaria-resistant mosquitoes have a fitness advantage when feeding on Plasmodium-infected blood," PNAS, March 27, 2007. 'http://www.pnas.orgH. Black, "Scientists refining methods for genetically altering insects," The Scientist, October 13, 1997. http://www.the-scientist.com/article/display/17744/M. Goozner, "Beating malaria," The Scientist, December 1, 2006. http://www.the-scientist.com/article/display/36878/Peter Atkinson http://www.facultydirectory.ucr.edu/cgi-bin/pub/public_individual.pl?faculty=86H. Hurd, "Manipulation of medically important insect vectors by their parasites," Annual Review of Entomology, 2003. 'http://www.the-scientist.com/pubmed/12414739Marcelo Jacobs-Lorena http://faculty.jhsph.edu/Default.cfm?faculty_id=659 F. Catteruccia et al., "Impact of genetic manipulation on the fitness of Anopheles stephensiaa mosquitoes," Science, February 21, 2003. http://www.the-scientist.com/pubmed/12595691J. Ito et al., "Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite," Nature, May 23, 2002. http://www.the-scientist.com/pubmed/12024215A.M. Ahmed, H. Hurd, "Immune stimulation and malaria infection impose reproductive costs in Anopheles gambiae via follicular apoptosis," Microbes and Infectiona, February 2006. http://www.the-scientist.com/pubmed/16213176Hilary Hurd http://www.keele.ac.uk/depts/aep/staff/hh.htmRobert Sinden http://www.bio.ic.ac.uk/research/res/sinden.htm
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series